Hatteras Venture Partners
- Company typePrivate
- Founded2000
- HeadquartersDurham, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
Hatteras Venture Partners firmographics
Firmographics- Name
- Hatteras Venture Partners
- Legal name
- Hatteras Venture Partners
- Website
- https://hatterasvp.com
- Company type
- Private
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Hatteras Venture Partners industry classification
Industry- Product category
- Healthcare Venture Capital
- NAICS
- Other Investment Pools and Funds (5259), Portfolio Management and Investment Advice (523940)
- akta.pro primary industry
- Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)
Keywords
Where Hatteras Venture Partners is headquartered
LocationHeadquarters
- HQ city
- Durham
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Hatteras Venture Partners business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Fund Management Fees: VC firm generates returns through management fees from limited partners (LPs) and carries interest from portfolio company exits and IPOs
- Portfolio Returns: Returns realized through successful exits of portfolio companies including acquisitions and IPOs
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Hatteras Venture Partners product offering
Product offeringCore offering
Hatteras Venture Partners is a healthcare-focused venture capital firm that provides early-stage equity capital, strategic guidance, and operational support to biotech, medtech, and healthtech companies. The firm manages multiple dedicated funds targeting transformational healthcare innovation, partnering with visionary founders on team recruitment, portfolio strategy, business development, regulatory, and clinical planning through to liquidity events.
Product overview
Hatteras Venture Partners is a healthcare-focused venture capital firm that does not offer products or services in the traditional sense. The firm provides investment capital, strategic guidance, and operational support to transformational healthcare companies across biotech, medtech, and healthtech sectors. Their investment approach encompasses dedicated funds including the Pisgah Fund (early-stage Western NC healthcare investments), Healthcare Innovation Venture Fund (HIVF, for hospital system partners WakeMed and Baptist Health), Carolina Research Ventures Fund (UNC-Chapel Hill startups), and Venture Capital Multiplier Fund (VCMF, for NC Nexus companies).
Differentiator
Problem solved
Functional benefit
Products and services
- Pisgah Fund Dedicated fund vehicle for early-stage venture capital investments targeting innovative healthcare companies in Western North Carolina.
- Healthcare Innovation Venture Fund (HIVF) Dedicated fund investing in early-stage healthcare companies developing technologies for member hospital systems including WakeMed Health & Hospitals and Baptist Health System, Inc. of Kentucky & Southern Indiana.
- Carolina Research Ventures Fund (CRV) Dedicated fund providing critical early-stage investments to startups emerging from UNC-Chapel Hill research.
- Venture Capital Multiplier Fund (VCMF) Dedicated fund for co-investments in North Carolina Nexus companies.
- HVP Series Funds (HVP II through HVP VII and HOF I) Flagship series of healthcare-focused venture capital funds (HVP II–HVP VII and HOF I) investing in transformational biotech, medtech, and healthtech companies from early stage through liquidity events.
Quantifiable outcome
- 100+ companies built over 25+ years
- +1 more outcomes
Companies that use Hatteras Venture Partners
Customer profileSegments2 records
Ideal customer profiles2 records
Hatteras Venture Partners technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Hatteras Venture Partners partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and minor.
- UNC-Chapel HillcoreCarolina Research Ventures Fund provides critical early-stage investments to startups emerging from UNC-Chapel Hill research
- Vertex PharmaceuticalscoreEstablished strategic collaboration with Ribometrix for RNA-targeted small molecule therapeutics, receiving $20 million upfront and potential milestones/royalties
- SanoficoreAcquired Vigil Neuroscience in 2025; strategic partnership with Kymera Therapeutics for targeted protein degradation medicines
- TakedacoreCollaboration and license agreement with StrideBio for novel gene therapies for neurological diseases
- Biohaven TherapeuticsminorOption and license agreement with Artizan Biosciences for up to three candidates for inflammatory bowel disease treatment
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
Hatteras Venture Partners competitors and assessment
Company assessmentDirect peers
- Pappas Capital: Pappas Capital is a Durham, NC-based venture capital firm investing in life sciences and healthcare companies across biotech, medtech, and healthtech. It is the most direct comparable to Hatteras given shared geography, sector focus, stage (early-stage), and LP base.
- Frazier Healthcare Partners: Frazier Healthcare Partners is a long-tenured (founded 1991), healthcare-dedicated venture and growth capital firm investing across therapeutics, medical devices, and healthcare services. It is highly comparable to Hatteras in sector focus, stage orientation, and tenure.
- 5AM Ventures: 5AM Ventures is an early-stage venture capital firm focused exclusively on life sciences, including biotech, pharma, and medtech. Direct competitor for healthcare-focused seed/Series A opportunities similar to Hatteras's deal mix.
- Versant Ventures: Versant Ventures is a healthcare-focused venture capital firm investing across biotech, medtech, and healthcare services with multiple funds and dedicated discovery engines. Comparable to Hatteras in sector specialization and stage orientation, though larger AUM.
- Atlas Venture: Atlas Venture is an early-stage venture capital firm focused on building breakthrough biotech companies, particularly in therapeutics. Direct peer in early-stage healthcare venture investing with similar founding/syndication model.
Broad incumbents
- ARCH Venture Partners: ARCH Venture Partners is one of the largest and longest-tenured early-stage healthcare and technology venture firms, with deep biotech, medtech, and deep-tech capabilities. Comparable to Hatteras in healthcare early-stage focus but materially larger AUM and broader scope.
- OrbiMed: OrbiMed is a leading global healthcare investment firm with venture, growth, credit, and royalty strategies across the entire healthcare value chain. Comparable to Hatteras in healthcare focus but operates at materially greater scale across multiple strategies.
- Bain Capital Life Sciences: Bain Capital Life Sciences is a dedicated life sciences investment platform within Bain Capital covering venture, growth, and public equities across biotech, medtech, and diagnostics. Comparable to Hatteras in healthcare venture focus but with significantly larger AUM.
- Sofinnova Partners: Sofinnova Partners is a European-headquartered life sciences venture capital firm investing across biotech, medtech, and industrial biotech. Comparable to Hatteras in healthcare early-stage focus; Hatteras has co-invested alongside Sofinnova (Atsena Therapeutics Series C).
Emerging players
- Lux Capital: Lux Capital invests in emerging science and technology ventures, including a growing healthcare and biotech practice spanning therapeutics, medtech, and healthtech. Comparable to Hatteras in sector-vertical investing but with broader tech exposure.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Hatteras Venture Partners social profiles
Digital presenceHatteras Venture Partners financial estimates
Financial estimateRevenue estimate
Valuation estimate
Hatteras Venture Partners leadership team
Management profileNumber of profiles
Profiles14 records
Hatteras Venture Partners subsidiaries and ownership
Company hierarchySubsidiaries4 records
Hatteras Venture Partners funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Hatteras Venture Partners M&A and investment
M&A and investmentM&A
Investments133 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Hatteras Venture Partners
What does Hatteras Venture Partners do?
Hatteras Venture Partners is a healthcare-focused venture capital firm that provides early-stage equity capital, strategic guidance, and operational support to biotech, medtech, and healthtech companies. The firm manages multiple dedicated funds targeting transformational healthcare innovation, partnering with visionary founders on team recruitment, portfolio strategy, business development, regulatory, and clinical planning through to liquidity events.
Is Hatteras Venture Partners a public or private company?
Hatteras Venture Partners is a private company. It is classified as management employee owned and is currently operating.
When was Hatteras Venture Partners founded?
Hatteras Venture Partners was founded in 2000. It employs 11 to 50 people.
Where is Hatteras Venture Partners based?
Hatteras Venture Partners is headquartered in Durham, United States, in the North America region.
How does Hatteras Venture Partners make money?
Two revenue lines are on record. Fund Management Fees are the primary driver. The others are portfolio Returns.
Who are Hatteras Venture Partners's main competitors?
Direct peers on record are Pappas Capital, Frazier Healthcare Partners, 5AM Ventures, Versant Ventures and Atlas Venture. Broad incumbents are ARCH Venture Partners, OrbiMed, Bain Capital Life Sciences and Sofinnova Partners. Lux Capital is listed as an emerging player.
Does Hatteras Venture Partners have an API?
No public API is recorded for Hatteras Venture Partners.
What industry is Hatteras Venture Partners in?
Hatteras Venture Partners's product category is Healthcare Venture Capital. Its primary akta.pro industry code is FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists). Its NAICS code is 5259.